A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

by | Dec 31, 2025 | Clinical Trials | 0 comments

​ Conditions: Healthy Participants

Interventions: Drug: Andexanet alfa; Drug: Rivaroxaban; Drug: Apixaban; Drug: Enoxaparin; Other: Placebo

Sponsors: AstraZeneca; Parexel

Not yet recruiting Conditions: Healthy Participants
Interventions: Drug: Andexanet alfa; Drug: Rivaroxaban; Drug: Apixaban; Drug: Enoxaparin; Other: Placebo
Sponsors: AstraZeneca; Parexel
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *